Pharmacologic treatment in postprostatectomy stress urinary incontinence

Area of Science:

• Urology
• Rehabilitation Medicine
• Pharmacology

Background:

• Radical retropubic prostatectomy (RRP) frequently leads to stress urinary incontinence (SUI) in men.
• Current management often involves pelvic floor muscle rehabilitation, but efficacy can be limited.
• Pharmacological adjuncts are being explored to enhance recovery of continence.

Purpose of the Study:

• To evaluate the efficacy and safety of combining duloxetine with rehabilitation for post-prostatectomy SUI.
• To compare this combination therapy against rehabilitation alone.
• To assess continence rates after a planned suspension of duloxetine.

Main Methods:

• 112 men with post-RRP SUI and at least four daily incontinent episodes were randomized.
• Group A received rehabilitation plus duloxetine; Group B received rehabilitation alone for 16 weeks.
• Incontinence Episode Frequency (IEF), Incontinence Quality of Life (I-QoL) scores, and pad use were assessed. Patients completed bladder diaries. Statistical analysis included Wilcoxon and Fisher exact tests.

Main Results:

• Duloxetine group (A) showed significantly greater decreases in IEF and improvements in I-QoL during the initial 16 weeks.
• At 16 weeks, significantly more patients in Group A were dry (39 vs. 27, p=0.007).
• After 4 weeks of duloxetine suspension (at 20 weeks), continence rates reversed, with more patients in Group B being dry (38 vs. 23, p=0.008).

Conclusions:

• Combination therapy of duloxetine and rehabilitation may enhance early postoperative continence in men with SUI.
• The observed benefit on continence appears temporary, diminishing after duloxetine discontinuation.
• This suggests duloxetine could be a valuable option for accelerating initial recovery from post-prostatectomy SUI.